Category: Infectious Diseases

A new North Carolina study called VISION is now underway to answer some of the biggest questions about COVID-19. Led by William Fischer, MD, principal investigator, and David Wohl, MD, co-lead, the study plans to enroll 7,500 COVID-positive individuals to understand the different factors that impact individual risk for key clinical outcomes including recovery from acute illness, symptom rebound, re-infection, and long COVID. Investigators explain the study more in video.

Read more

David Weber, MD, MPH, was elected as the incoming vice president of the Society for Healthcare Epidemiology of America (SHEA) during the group’s meeting held in conjunction with Infectious Diseases Week, an international conference, in Washington, D.C., in October.

Read more

Benny Joyner, MD, MPH, spoke about the rise in hospitalizations due to RSV in the inaugural podcast for UNC Children's Hospital.

Read more

UNC Institute for Global Health and Infectious Diseases and critical care experts William Fischer, MD, and David Wohl, MD, in collaboration with UNC Hospitals colleagues, will lead a Regional Emerging Special Pathogen Treatment Center funded through the U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response.

Read more

The Doris Duke Charitable Foundation awarded more than $7.9 million in grants to 16 early-career physician scientists, including two from the UNC School of Medicine – Andrea Knittel, MD, PhD and Peyton Thompson, MD.

Read more

An independent expert advisory committee recommended 21-0 that the FDA grant emergency use authorization for a fourth COVID-19 vaccine, made by Novavax. Cindy Gay, MD, MPH, discusses the Novavax data, its effectiveness, and how it's different from the other three COVID-19 vaccines.

Read more

CASP created the awards in 2022 to recognize colleagues’ efforts to champion stewardship in their settings.

Read more

Led by Michelle Floris-Moore, MD, and Joe Eron, MD, this effort at UNC is one 11 infectious diseases divisions across the country selected for this pilot program launched by the Infectious Diseases Society of America with the CDC.

Read more

Melissa Miller, PhD, director of the Clinical Molecular Microbiology Laboratory at UNC Medical Center, talks with the News and Observer about why an at-home COVID test might give false-negative results and tips on how to determine if follow-up testing is needed.

Read more

A study published in The Lancet Digital Health led by UNC School of Medicine’s Emily R. Pfaff, PhD, shows how the National COVID Cohort Collaborative used XGBoost machine learning models to better define long COVID and identify potential long COVID patients with a high degree of accuracy.

Read more

This virtual seminar series will provide a background in the use of machine learning tools to answer clinical questions, understand the strengths and limitations of these methods, and examine real-world examples of machine learning methodology in clinical research. The series is co-sponsored by the UNC Core Center for Clinical Research and the UNC Program for Precision Medicine in Health Care.

Read more

UNC-Chapel Hill scientists led by Camille Ehre, PhD, show how cells packed with SARS-CoV-2 detach from the upper airway and spread deep into lungs where severe COVID can take root. They also discovered how an asthmatic reaction to allergens battles the virus to hold severe COVID at bay.

Read more